Sanara MedTech Inc. (SMTI)

Compare

32.47

+0.24

+(0.73%)

As of 3:01:03 PM EST. Market Open.

Sanara MedTech to Present at the Piper Sandler 36th Annual Healthcare Conference on December 4th

FORT WORTH, TX, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, announced today that Ron Nixon, the Company’s Chairman and Chief Executive Officer, will present at the

GlobeNewswire last month

SMTI
+0.73%
Sanara MedTech Inc. (NASDAQ:SMTI) Just Reported Earnings, And Analysts Cut Their Target Price

Sanara MedTech Inc. ( NASDAQ:SMTI ) just released its latest quarterly results and things are looking bullish. Results...

Simply Wall St. last month

SMTI
+0.73%
Sanara MedTech Third Quarter 2024 Earnings: Beats Expectations

Sanara MedTech ( NASDAQ:SMTI ) Third Quarter 2024 Results Key Financial Results Revenue: US$21.7m (up 35% from 3Q...

Simply Wall St. last month

SMTI
+0.73%
Sanara MedTech Inc (SMTI) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...

Sanara MedTech Inc (SMTI) achieves its 12th consecutive record revenue quarter, while navigating increased expenses and strategic expansions.

GuruFocus.com last month

SMTI
+0.73%
Sanara MedTech Inc. Reports Third Quarter 2024 Results

FORT WORTH, TX, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, today reported its strategic, operational and financial results for the quarter ended September 30, 202

GlobeNewswire last month

SMTI
+0.73%
Sanara MedTech Inc. (NASDAQ:SMTI) insiders have significant skin in the game with 30% ownership

Key Insights Sanara MedTech's significant insider ownership suggests inherent interests in company's expansion A total...

Simply Wall St. 2 months ago

SMTI
+0.73%
Sanara MedTech Inc. Announces Third Quarter Earnings Release and Conference Call Dates

FORT WORTH, TX, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, today announced details for the release of its results for the quarter ended September 30, 2024. Sanara

GlobeNewswire 2 months ago

SMTI
+0.73%
Sanara MedTech Inc. Announces Changes to Its Board of Directors

FORT WORTH, TX, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. -- Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara” or the “Company”) (NASDAQ: SMTI), a medical technology company focused on improving clinical outcomes and reducing healthcare expenditures in the surgical, chronic wound and skincare markets announced today changes to its Board of Directors (“Board”). After a long tenure of service with the predecessor company and Sanara, Mr. James “Jim” Stuckert has resigned from hi

GlobeNewswire 3 months ago

SMTI
+0.73%
Sanara MedTech's (NASDAQ:SMTI) investors will be pleased with their solid 259% return over the last five years

Sanara MedTech Inc. ( NASDAQ:SMTI ) shareholders have seen the share price descend 12% over the month. But in stark...

Simply Wall St. 3 months ago

SMTI
+0.73%
Sanara MedTech Inc. and InfuSystem Holdings, Inc. Announce Exclusive United States Distribution Agreement with, and Minority Investment in, ChemoMouthpiece, LLC

FORT WORTH, TX, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on improving clinical outcomes and reducing healthcare expenditures in the surgical, chronic wound and skincare markets, and InfuSystem, Inc. (“InfuSystem”), the operational subsidiary of Sanara’s joint venture partner InfuSystem Holdings, Inc., announced today the execution of an

GlobeNewswire 4 months ago

SMTI
+0.73%
INFU
Sanara MedTech Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Sanara MedTech ( NASDAQ:SMTI ) Second Quarter 2024 Results Key Financial Results Revenue: US$20.2m (up 28% from 2Q...

Simply Wall St. 4 months ago

SMTI
+0.73%
Sanara MedTech Inc. Announces Second Quarter 2024 Results

FORT WORTH, TX, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, announced today its strategic, operational and financial results for the quarter ended June 30, 2024. R

GlobeNewswire 4 months ago

SMTI
+0.73%
Sanara MedTech Inc. Announces Second Quarter Earnings Release and Conference Call Dates

FORT WORTH, TX, July 30, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, today announced details for the release of its results for the quarter ended June 30, 2024. Sanara will

GlobeNewswire 5 months ago

SMTI
+0.73%
Sanara MedTech Inc (SMTI) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth Amid ...

Despite a rise in revenue and strategic advancements, increased losses and operational costs pose hurdles for Sanara MedTech Inc.

GuruFocus.com 7 months ago

SMTI
+0.73%
Sanara MedTech Inc. Reports First Quarter 2024 Results: Revenue Surges, Losses Widen

Analysis of Financial Performance and Strategic Developments

GuruFocus.com 7 months ago

SMTI
+0.73%
Sanara MedTech Inc. Announces First Quarter 2024 Results

FORT WORTH, TX, May 13, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, announced today its strategic, operational and financial results for the quarter ended March 31, 2024. R

GlobeNewswire 7 months ago

SMTI
+0.73%
Insiders own 30% of Sanara MedTech Inc. (NASDAQ:SMTI) shares but individual investors control 32% of the company

Key Insights The considerable ownership by individual investors in Sanara MedTech indicates that they collectively have...

Simply Wall St. 7 months ago

SMTI
+0.73%
Sanara MedTech Inc. Announces First Quarter Earnings Release and Conference Call Dates

FORT WORTH, TX, April 29, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, today announced details for the release of its results for the quarter ended March 31, 2024. Sanara wi

GlobeNewswire 8 months ago

SMTI
+0.73%
Sanara MedTech Inc. Announces $55 Million Debt Facility

FORT WORTH, TX, April 18, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, announced today that it has entered into a $55.0 million non-dilutive term loan agreement with CRG Ser

GlobeNewswire 8 months ago

SMTI
+0.73%
Sanara MedTech Inc. Announces the Appointments of Jake Waldrop as Chief Operating Officer and Tyler Palmer as Chief Corporate Development and Strategy Officer

FORT WORTH, TX, April 05, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, announced today the appointments of Jake Waldrop as Chief Operating Officer and Tyler Palmer as Chief

GlobeNewswire 9 months ago

SMTI
+0.73%

Performance Overview

Return	SMTI	S&P 500
YTD	-2.18%	-1.41%
1-Year	-16.39%	+21.74%
3-Year	+22.51%	+23.22%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Sanara MedTech Inc. (SMTI)

Sanara MedTech to Present at the Piper Sandler 36th Annual Healthcare Conference on December 4th

Sanara MedTech Inc. (NASDAQ:SMTI) Just Reported Earnings, And Analysts Cut Their Target Price

Sanara MedTech Third Quarter 2024 Earnings: Beats Expectations

Sanara MedTech Inc (SMTI) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...

Sanara MedTech Inc. Reports Third Quarter 2024 Results

Sanara MedTech Inc. (NASDAQ:SMTI) insiders have significant skin in the game with 30% ownership

Sanara MedTech Inc. Announces Third Quarter Earnings Release and Conference Call Dates

Sanara MedTech Inc. Announces Changes to Its Board of Directors

Sanara MedTech's (NASDAQ:SMTI) investors will be pleased with their solid 259% return over the last five years

Sanara MedTech Inc. and InfuSystem Holdings, Inc. Announce Exclusive United States Distribution Agreement with, and Minority Investment in, ChemoMouthpiece, LLC

Sanara MedTech Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Sanara MedTech Inc. Announces Second Quarter 2024 Results

Sanara MedTech Inc. Announces Second Quarter Earnings Release and Conference Call Dates

Sanara MedTech Inc (SMTI) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth Amid ...

Sanara MedTech Inc. Reports First Quarter 2024 Results: Revenue Surges, Losses Widen

Sanara MedTech Inc. Announces First Quarter 2024 Results

Insiders own 30% of Sanara MedTech Inc. (NASDAQ:SMTI) shares but individual investors control 32% of the company

Sanara MedTech Inc. Announces First Quarter Earnings Release and Conference Call Dates

Sanara MedTech Inc. Announces $55 Million Debt Facility

Sanara MedTech Inc. Announces the Appointments of Jake Waldrop as Chief Operating Officer and Tyler Palmer as Chief Corporate Development and Strategy Officer

Performance Overview